| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 6e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |